This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Does Vancomycin Resistance Affect Mortality?

Mark R. Mainous, MD; Pamela A. Lipsett, MD; Maureen O'Brien, RN

Arch Surg. 1997;132(1):76-81.

Abstract
Objective
To determine the incidence and mortality rate associated with nosocomial bacteremia caused by vancomycin-resistant Enterococcus in a surgical intensive care unit.

Design
A retrospective study.

Setting
The surgical intensive care unit of a large university hospital tertiary referral center.

Patients
All patients in the surgical intensive care unit with a documented nosocomial bacteremia between January 1, 1992, and December 31, 1994.

Interventions
None.

Main Outcome Measure
Mortality rate.

Results
Of the 134 nosocomial bacteremic episodes, 30.6% involved enterococci; 24.4% of the enterococci were resistant to vancomycin. Patients with vancomycin-resistant enterococcal bacteremia had a significantly longer hospital stay (mean±SD, 28±18 vs 12±10 days; P=.005) and were more likely to have been treated with vancomycin (70% vs 10.3%; P=.001) than patients with vancomycin-sensitive enterococcal bacteremia. The mortality (41.0%) associated with enterococcal bacteremia was similar to the overall bacteremic mortality (41.7%). There was no difference in episode-specific mortality associated with vancomycin-resistant enterococci (40%) vs vancomycin-sensitive enterococci (38.7%). Of the 4 deaths associated with vancomycin-resistant enterococcal bacteremia, only 2 occurred within 14 days of the bacteremia, as did 8 of 12 deaths associated with vancomycin-sensitive enterococcal bacteremia (P=.64).

Conclusions
Enterococci were the most commonly isolated nosocomial blood-borne pathogens in the surgical intensive care unit. Nearly 25% of the enterococcal bacteremic episodes were resistant to vancomycin. Vancomycin-resistant Enterococcus is associated with a prolonged hospital stay and with vancomycin use. Nevertheless, vancomycin resistance itself does not increase the mortality rate associated with enterococcal bacteremia.

Arch Surg. 1997;132:76-81

Author Affiliations
From the Department of Surgery, Division of Trauma, Louisiana State University Medical Center, Shreveport (Dr Mainous), and the Departments of Surgery (Dr Lipsett) and Infection Control (Ms O'Brien), The Johns Hopkins Medical Institutions, Baltimore, Md. A complete list of the Johns Hopkins SICU Study Group appears on page 80.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nosocomial Infections Due to Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: Relationships with Antibiotic Use and Cost Drivers
Mauldin et al.
The Annals of Pharmacotherapy 2008;42:317-326.
ABSTRACT | FULL TEXT  

Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit
Martinez et al.
Arch Intern Med 2003;163:1905-1912.
ABSTRACT | FULL TEXT  

Antibiotic Resistance in the Intensive Care Unit
Kollef and Fraser
ANN INTERN MED 2001;134:298-314.
ABSTRACT | FULL TEXT  

The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
Ibrahim et al.
Chest 2000;118:146-155.
ABSTRACT | FULL TEXT  

Prediction of Poorer Prognosis by Infection With Antibiotic-Resistant Gram-positive Cocci Than by Infection With Antibiotic-Sensitive Strains
Gleason et al.
Arch Surg 1999;134:1033-1040.
ABSTRACT | FULL TEXT